Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities and individuals who say they were harmed by the company’s addictive ...

NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...

The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than 54,000 ...

All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced ...

In Harrington v. Purdue Pharma L.P., the Supreme Court issued a landmark ruling holding that “the bankruptcy code does not authorize a release and injunction that, as part of a plan of reorganization ...

The company that makes the prescription painkiller OxyContin would be transformed into a new entity that would funnel profits into combatting the U.S. opioid crisis under a $10 billion plan submitted ...

After gaining resounding creditor support, Purdue Pharma's settlement plan now needs to secure court approval.